Evidence map›Paper›PMID 36835333›Full record

ArticleInternational journal of molecular sciences2023

In Vitro Photoinactivation of

Sara R D Gamelas, Isabel N Sierra-Garcia, Augusto C Tomé, Ângela Cunha, Leandro M O Lourenço

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 8 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Sara R D GamelasLAQV-REQUIMTE, Department of Chemistry, University of Aveiro, 3810-193 Aveiro, Portugal.ORCID 0000-0003-4688-8570
Isabel N Sierra-GarciaCESAM, Department of Biology, University of Aveiro, 3810-193 Aveiro, Portugal.ORCID 0000-0001-6373-2901
Augusto C ToméLAQV-REQUIMTE, Department of Chemistry, University of Aveiro, 3810-193 Aveiro, Portugal.ORCID 0000-0003-4331-714X
Ângela CunhaCESAM, Department of Biology, University of Aveiro, 3810-193 Aveiro, Portugal.ORCID 0000-0002-9118-3521
Leandro M O LourençoLAQV-REQUIMTE, Department of Chemistry, University of Aveiro, 3810-193 Aveiro, Portugal.ORCID 0000-0003-1624-6825
Rede de Química e Tecnologia · PTUniversity of Aveiro · PT

Funding

Fundação para a Ciência e Tecnologia P2020-PTDC/QUI-QOR/31770/2017Fundação para a Ciência e Tecnologia SFRH/BD/143549/2019Fundação para a Ciência e Tecnologia UIDB/50006/2020Fundação para a Ciência e Tecnologia UIDP/50006/2020Fundação para a Ciência e Tecnologia UIDP/50017/2020 + UIDB/50017/2020 + LA/P/0094/2020
6 · The paper itself

Abstract

Antimicrobial photodynamic therapy (aPDT) has been explored as an innovative therapeutic approach because it can be used to inactivate a variety of microbial forms (vegetative forms and spores) without causing significant damage to host tissues, and without the development of resistance to the photosensitization process. This study assesses the photodynamic antifungal/sporicidal activity of tetra- and octasubstituted phthalocyanine (Pc) dyes with ammonium groups. Tetra- and octasubstituted zinc(II) phthalocyanines (

Indexed as

Antifungal AgentsPhotochemotherapyFusariumIndolesIsoindolesLightPhotosensitizing AgentsSpores, FungalAntifungal AgentsIndolesIsoindolesPhotosensitizing Agentsphthalocyanineantimicrobial photodynamic therapy (aPDT)cationic phthalocyaninesFusarium oxysporum conidiareactive oxygen species (ROS)singlet oxygen

Identifiers

PMID36835333
PMCPMC9966838
OpenAlexW4320918568

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.